CD8A and cancer: Elevated CD68 expression levels (higher amount of macrophages) increased the activation of antigen-presentation-associated pathways in macrophages and dendritic cells with simultaneously even levels of CD8+ CTL, and no signs of direct anti-cancer immune aggression (like an expression of perforin or granzymes), implies altered processing of tumor neoantigens.